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ABSTRACT 
 
The tuberculosis (TB) disease to this day remains one of the world’s prominent killer 
diseases. Pyrazinamide (PZA) is one of the most commonly prescribed anti-
tuberculosis (anti-TB) drugs due to its ability to significantly shorten the TB treatment 
period from the former nine months to the current six months duration. However, 
excess PZA in the body causes hepatotoxicity and damages the liver. This 
hepatotoxicity, together with the resistance of the bacteria to treatment drugs, poor 
medication and inappropriate dosing, greatly contribute to the high incidents of TB 
deaths and diseases that are due to side effects (such as liver damage). This brings 
about the calls for alternative methods for ensuring reliable dosing of the drug, which 
will be specific from person to person due to inter-individual differences in drug 
metabolism. A novel biosensor system for monitoring the metabolism of PZA was 
prepared with a Ni-PPI-PPy star copolymer and cytochrome P450 2E1 (CYP2E1) 
deposited onto a platinum electrode. The nanobiosensor system exhibited enhanced 
electro-activity that is attributed to the catalytic effect of the incorporated star 
copolymer. The biosensor had a sensitivity of 0.142 µA.nM-1, and a dynamic linear 
range (DLR) of 0.01 nM-0.12 nM (1.231 – 7.386 ng/L PZA). The limit of detection of 
the biosensor was found to be 0.00114 nM (0.14 ng/L) PZA. From the HPLC peak 
concentration (Cmax) of PZA determined 2 h after drug intake is 2.79 – 3.22 ng.L
-1
, 
which is very detectable with the nanobiosensor as it falls within the dynamic linear 
range. 
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INTRODUCTION 
 
Summary 
This chapter describes the aspects involved in the study namely; Dendrimers, sensors, 
cytochrome P450 enzymes (with particular emphasis on CYP450 2E1), tuberculosis, and 
anti-tuberculosis treatment drugs in which the study will focus on pyrazinamide as a 
model drug. The focus of this chapter is the relationship between all of these aspects and 
the manner in which they contribute towards the success and applicability of this study. 
The chapter also includes the problem statement, motivation, aim and objectives of the 
study as well as the thesis outline. 
 
1.1. Background 
Tuberculosis (TB) is an infectious disease that is caused by the bacteria bacillus 
Mycobacterium tuberculosis. TB classically affects the lungs (pulmonary TB) but can 
affect other sites as well (extrapulmonary TB). TB spreads in the air when people who are 
infected with the pulmonary TB eject the bacteria, by coughing as an example. TB 
remains one of the world’s deadliest communicable diseases. In 2013, an estimated 9.0 
million people developed TB and 1.5 million died from the disease, 360 000 of whom 
were HIV-positive [1]. Mycobacterial infections are one of the most difficult bacterial 
infections to treat, let alone cure. This is because mycobacteria are organisms that grow at 
a slow rate, which makes them relatively resistant to antibiotics, an activity of which tends 
to depend on how rapidly the cells are dividing [2]. Most people who are exposed to TB 
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never develop symptoms because the bacteria can live in an inactive form in the body for 
years without being activated. Due to the fact that these latent infections can ultimately 
become active, even people who show no symptoms should receive medical treatment. In 
such cases, the therapy gets rid of the inactive bacteria before they become active. Inactive 
mycobacterial cells can be completely resistant to many drugs, or at times be slowly killed 
by drugs that are active [1]. When the immune system weakens, such as in people who are 
infected with the HIV or elderly persons, the bacteria can be activated. In their active 
state, TB bacteria cause death to the tissue of the infected organs. Active TB disease can 
be fatal if it is left untreated. A considerable amount of mycobacterial cells are 
intracellular, they reside inside macrophages which makes them practically unreachable to 
drugs that struggle to infiltrate the macrophages [1]. These organisms, infamous for 
developing resistance to any single drug, therefore, require a combination drug therapy to 
successfully overcome such obstacles and also prevent the development of resistance 
during therapy. Another alternative approach to eliminating mycobacteria is 
chemotherapy. The drawback of this approach is that it is a slow means of therapy 
whereby treatment can drag on for months to years, depending on the drugs used [2].  
Tuberculosis is one of the main subjects of this study, and is a disease resulting from 
infection, primarily, by Mycobacterium tuberculosis which is the most prominent 
infecting organism. There are, on the other hand, other rare mycobacteria that can give 
rise to the development of TB such as Mycobacterium bovis, which is infrequent because 
of the practical eradication of bovine tuberculosis from cattle as well as Mycobacterium 
africanum, which is usually found in parts of Africa [2].  
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There exists a clear difference between tuberculosis infection and tuberculosis disease. In 
the case of tuberculosis disease, one or more body parts show bacteriological, clinical and 
radiographic evidence of the disease while in the case of tuberculosis infection; the 
tubercle bacilli are established in the host with no symptoms or detectable evidence of the 
disease. During the last few decades, TB infections and fatality rate has decreased 
gradually [3]. This could be attributed to a combination of improved social conditions, 
better nutrition, less overcrowding, freely available vaccination and case-finding 
programmes [2]. There has been a global decrease in new TB cases since 2003, but 
despite that, developing counties in Africa are still feeling the effects of the disease. In 
2006 South Africa recorded the world’s second highest rate of new cases after Swaziland 
[1]. More people died of TB in South Africa in that year than in any other country in the 
world, at a rate of 218 per 100 000. Zimbabwe and Mozambique had the next highest TB 
death rates. The global TB cure rate for 2005 was 78%, but South Africa’s cure rate was 
only 58%. This was third worst in the world. Uganda was bottom of the class with a 32% 
cure rate, followed by Russia with a 55% cure rate. Zimbabwe did marginally better than 
South Africa with a 59% cure rate. In underdeveloped and developing countries, TB 
continues to be problematic especially with the emergence of drug resistant strains and the 
high rates of HIV/AIDS [3].  
 
The most recent global TB estimates show that 9 million people developed TB in 2013 
and 1.5 million fatalities resulted from the disease [1]. Of the estimated 9 million people 
who developed TB in 2013, more than half (56%) were in the South-East Asia and 
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Western Pacific Regions. A further one quarter was in the African Region, which also had 
the highest rates of new cases and deaths relative to population [3]. The persistence of 
high infection rates in these countries can be accredited to the lack of proper public 
infrastructure and the accelerated weakening of the immune system of the individuals who 
are infected with the HIV/AIDS. 
The directly observed treatment short course (DOTS) regime has played a key and 
significant role in reducing the infection and death rates of TB. However, failure to 
complete the treatment as well as inappropriate dosing, have also been a major cause of 
the high occurrences of the drug resistant strains of TB [2]. The spread of HIV/AIDS in 
tuberculosis-endemic regions also plays a role in the development of the TB drug resistant 
strains. This is due to the fact that patients with fully susceptible tuberculosis develop 
secondary resistance during therapy, resulting from inappropriate dosing of treatment 
drugs, inadequate treatment, not taking the prescribed regimen appropriately or using low 
quality medication [2]. Multidrug-resistant TB (MDR-TB) and extensively drug resistant 
TB (XRD-TB) are both the TB drug resistant strains which are more difficult to treat than 
sensitive tuberculosis, since they require the administration of expensive and less effective 
second line drugs for longer treatment durations than first line drugs [1,2]. This highlights 
the need for new approaches to remedy the situation of patients becoming sick because of 
inappropriate dosing and inadequate administration of the treatment drugs. 
In order for that to be achieved, a device that has a fast response time together with an 
enhanced performance and increased sensitivity is fundamental. This type of a device can 
only become a possibility by adopting the lab-on-a-chip principle, which is obtained by 
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the reducing the size of bulky lab equipment and integrating them onto a single chip. The 
size reduction is paramount because it brings about ease of convenience, portability, low 
costs, high resolution results, ease of operation, rapidity of analysis and reduced amounts 
of chemical or sample consumption [4]. Amongst the methods currently used for 
miniaturization is the integration of chemical techniques and procedures into 
electrochemical nanobiosensors. An electrochemical nanobiosensor consists of two parts, 
one where the requisite chemical or physical processes are performed and the second part 
for the acquirement of information [3]. Nanobiosensors require a biological element such 
as DNA or enzymes to be integrated into the sensing material [5, 6]. These biological 
elements are responsible for the determination of the analyte. The transducer component 
of the biosensor works physic.-chemically; it can either be optical, piezoelectric or 
electrochemical. The role of the transducer component is to transform the resultant signal 
from the sensitive biological element and analyte into another signal that is easily 
measured, quantified and interpreted [3]. Transducer elements in electrochemical 
biosensors, modified electrodes are often used as transducer elements, these electrodes can 
be coated with electric conducting substances such as quantum dots and conducting 
polymers, amongst others [7]. Conducting polymers are nanomaterials that have a large 
surface area and catalytic behaviour which gives them enhanced performance and 
properties [8]. Literature has revealed that incorporation of metal nanoparticles onto 
polymers results in nanocomposites of enhanced electrochemical activity, thereby yielding 
biosensors with high selectivity, sensitivity and faster response times [3]. 
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1.2. Problem statement and motivation 
Pyrazinamide (PZA) is a first line pro-drug in the TB combination chemotherapy where it 
is administered in conjunction with rifampicin, ethambutol and isoniazid. PZA (Figure 1) 
is very active against the old bacilli of mycobacterium tuberculosis that duplicate slowly 
and cannot be killed by the other anti-tuberculosis drugs [2]. People do not metabolize 
drugs at the same rate and are categorized into three classes according to the rate at which 
they metabolize drugs, namely slow, moderate and fast metabolizers. The medical 
prescription assumes that everyone is a moderate metabolizer since the metabolic profile 
of patients is not known. This leads to greater chances of liver damage and hepatotoxicity 
induced by the accumulation of the drug and/or its metabolites. As a result, regulatory 
bodies such as FDA and WHO have set minimal inhibitory concentrations (MIC) for 
therapeutic drugs, with an MIC of 50–100 mg/L for PZA [1, 9-10] reports from bodies 
implemented to monitor TB (e.g. the DOTS, STOP-TB and TAC), have shown success in 
combating TB spread and recurrence, tuberculosis remains a major health problem in 
South Africa. This is enhanced by factors such as over-crowding (since TB is a respiratory 
disease spread easily through coughing and breathing), and poor health seeking behaviour 
(mainly in rural areas which constitute larger population percentages), leading to delayed 
detection of diseases. Above all, the TB-HIV correlation plays a vital part with 73% of TB 
patients being HIV positive [1]. Also, a recent report has confirmed that PZA metabolites 
are responsible for hepatotoxicity [3]. Hence, there is an increased demand for onsite 
analytical devices that can quantitatively and qualitatively allow monitoring of PZA (and 
other therapeutic drugs) with high sensitivity, selectivity and faster response time and 
lower detection limits [9].  
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In this study we employed a conducting polymer to promoter electron transfer, conducting 
polymers are organic materials that exhibit both metallic and semi-conductive nature and 
have a conjugation of σ electrons (single bonds) and π (double bonds) along their 
backbone. Conducting polymers have been used as biosensor platforms due to alternating 
single and double bonds in the polymer chain, this special conjugation along their chain 
enables them to de-localize the electrons throughout the whole system resulting in them 
being shared by many atoms. 
 
Figure 1: Structure of pyrazinamide [10]. 
1.3. Aims and Objectives 
 
The main aim of this study was to prepare a nanobiosensor system for monitoring the 
metabolism of the anti-TB drug, pyrazinamide. The platform of the biosensor consisted of 
a nickel-poly(propylene imine)-co-polypyrrole dendrimeric star copolymer and CYP2E1 
enzyme. The enzyme was employed to act as the receptor of the sensor which will interact 
with the drugs while the dendrimeric star copolymer will promote electron transfer 
between the enzyme and the electrode.  
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In this research study a quantitative research approach was applied and the aim was 
achieved through the following objectives: 
 Synthesis of G2 PPI-2Py. 
 Synthesis of nickel-poly(propylene imine) (Ni-PPI-2Py) metallodendrimer. 
 Fourier Transform Infrared Radiation Spectroscopic characterization of Ni-PPI-
2Py metallodendrimer. 
 Microscopic analysis of the of Ni-PPI-2Py metallodendrimer. 
 Electropolymerization of Ni-PPI-2Py modified Pt electrode to form Ni-PPI-PPY 
star copolymer. 
 Electroanalysis of the Ni-PPI-PPY star copolymer-modified Pt using cyclic 
voltammetry (CV). 
 Incorporation of CYP2E1 onto the Ni-PPI-PPY star copolymer modified Pt 
electrode resulting in Pt/Ni-PPI-PPY star copolymer/ CYP2E1 biosensor 
 Electrochemical testing of the Pt/Ni-PPI-PPY star copolymer/ CYP2E1 biosensor 
response in the presence and absence of pyrazinamide using CV.  
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1.4. Thesis layout 
This thesis is presented in 6 chapters 
 
Chapter 1: Gives brief background information on the project, problem statement and 
motivation as well as aims and objectives. 
Chapter 2: Provides a detailed literature review. 
Chapter 3: Consists of reagents, procedures and instrumentations used for the success of 
this study. 
Chapter 4: Provides the characterization of the PPI-2Py dendrimer, Ni-PPI-2Py 
metallodendrimer and the developed Pt/Ni-PPI-PPY star copolymer/ CYP2E1 biosensor. 
Importantly it also covers results and discussion for PZA detection. 
Chapter 5: Provides the conclusion and recommendations. 
Chapter 6: Provides references. 
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LITERATURE REVIEW 
 Summary 
This chapter gives an introduction to electrochemical biosensors, components of an 
electrochemical biosensor and types of interactions involved in biosensors. This chapter 
also includes an introduction to conducting polymers, dendrimers and the synthesis of 
dendrimers. 
2.1. Electroanalytical techniques 
Electroanalytical techniques are concerned with the relationship between electricity and 
chemistry, specifically the measurement of electrical quantities such as current, potential 
or charge and their relationship to chemical parameters such as concentration. The use of 
electrical measurements for analytical purposes has found consideration in a large range 
of applications including environmental monitoring, industrial quality control and 
biomedical analysis. Amongst the devices that make use of electroanalytical techniques, 
biosensors are the most recently studied for quantitative and qualitative detection of 
various species such as drugs and hazardous chemicals, due to the negative impacts they 
pose on human health through their side effects. Biosensors have been getting much 
attention due to their properties such as portability, low cost and lower detection limits. 
These properties give biosensors application in a wide range of fields. This chapter gives 
an introduction to conducting polymers, their properties and their application in the field 
of biosensors. This chapter also gives a detailed background on different types of 
biosensors, the different components of a biosensor, the Cytochrome P450 enzyme family 
(the enzyme used in this study is CYP2E1) and tuberculosis. 
 
 
 
 
13 
 
2.2. Electrochemical biosensors 
 
Figure 2: The components of a biosensor [11]. 
 
A biosensor is an analytical device which combines a biological component with a 
physicochemical detector to detect an analyte [11, 12-14]. A biosensor consists of three 
components, namely, the sensitive biological element, the transducer and the signal 
processor. The sensitive biological element is a biologically derived material such as an 
enzyme, nucleic acid or a synthetic component that mimics a biological component [12, 
15]. This biological element interacts with the analyte under study by recognizing and 
binding onto it [7, 8]. 
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The transducer component of the biosensor works physico-chemically; it can either be 
optical, piezoelectric or electrochemical. The role of the transducer component is to 
transform the resultant signal from the sensitive biological element and analyte into 
another signal that is easily measured, quantified and interpreted [12, 16]. 
The biosensor signal processors are principally responsible for the display of the results in 
a convenient manner. This is typically the most expensive part of the sensor device. 
2.2.1. Types of bioreceptors 
Biosensor operations are dependent on the details of the sensor design. Biosensors make 
use of different biological and transduction elements; these can be grouped according to 
either of the two elements. 
2.2.1.1. Antibody/antigen Interactions 
An immunosensor exploits the very specific binding affinity of antibodies for an antigen. 
The specific nature of the antibody-antigen interaction is comparable to that of a lock and 
key fit in the sense that the antigen will only bind to the antibody if, and only if, it has the 
correct conformation [12]. Binding events result in a physicochemical change that, in 
combination with a tracer such as fluorescent molecules, enzymes or radioisotopes, can 
generate a signal. However, there are limitations with using antibodies in sensors. Firstly, 
the antibody binding capacity is strongly dependent on assay conditions (e.g. pH and 
temperature) and secondly, the antibody-antigen interaction is generally irreversible. 
However, it has been shown that binding can be disrupted by chaotropic reagents, organic 
solvents, or even ultrasonic radiation [17]. 
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2.2.1.2. Enzymatic Interactions 
The specific binding abilities and catalytic activity of enzymes make them popular 
bioreceptors . Analyte recognition is allowed through several possible mechanisms such 
as: 1) the enzyme converting the analyte into a product that is sensor-detectable, 2) 
detecting enzyme inhibition or activation by the analyte, or 3) monitoring modification of 
enzyme properties resulting from interaction with the analyte [18]. The main reasons for 
the common use of enzymes in biosensors are: 1) ability to catalyze a large number of 
reactions; 2) potential to detect a group of analytes (substrates, products, inhibitors, and 
modulators of the catalytic activity); and 3) suitability with several different transduction 
methods for detecting the analyte. The major advantages of using enzymes as the 
receptors are that, since enzymes are not consumed in reactions, the biosensor can easily 
be used continuously, and that the catalytic activity of enzymes also allows lower limits of 
detection compared to common binding techniques. However, the sensor's lifetime is 
limited by the stability of the enzyme [19]. 
2.2.1.3. Nucleic acid Interactions 
Biosensors that employ nucleic acid interactions can be referred to as genosensors. The 
recognition process is based on the principle of complementary base pairing of adenine 
with thymine and cytosine with guanine in DNA. If the target nucleic acid sequence is 
known, complementary sequences can be synthesized, labelled and then, be immobilized 
on the sensor [19]. The hybridization probes can then base pair with the target sequences, 
generating an optical signal. The favoured transduction principle employed in this type of 
sensor has been optical detection [12]. 
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2.2.2. Types of transducer elements 
2.2.2.1. Resonance  
In this type of a biosensor, an acoustic wave transducer is attached to an antibody. When 
the analyte molecule (antigen) gets attached to the membrane, the mass of the membrane 
changes. The resultant change in mass subsequently changes the resonant frequency of the 
transducer. This frequency change is then measured [12]. 
2.2.2.2. Optical 
In this type of a biosensor, measured light is the output transduced signal. The biosensor 
can be made based on either optical diffraction or electrochemiluminescence. In optical 
diffraction-based devices, a silicon wafer is coated with a protein via covalent bonds. The 
wafer is then exposed to UV light through a photo-mask and the antibodies become 
inactive in the exposed regions. When the diced wafer chips are incubated in an analyte, 
antigen-antibody bindings are formed in the active regions, thus creating a diffraction 
grating. This grating produces a diffraction signal when illuminated with a light source 
such as a laser. The resulting signal can be measured or can be further amplified before 
measuring for improved sensitivity [12]. 
2.2.2.3. Thermal 
This type of a biosensor makes use of one of the primary properties of biological 
reactions, namely absorption or production of heat, which in turn changes the temperature 
of the medium in which the reaction takes place. They are constructed by combining 
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immobilized enzyme molecules with temperature sensors. When the analyte comes in 
contact with the enzyme, the heat reaction of the enzyme is measured and is calibrated 
against the analyte concentration. The total heat produced or absorbed is proportional to 
the molar enthalpy and the total number of molecules in the reaction. The measurement of 
the temperature is typically accomplished via a thermistor, and such devices are known as 
enzyme thermistors. Their high sensitivity to thermal changes makes thermistors ideal for 
such applications. Unlike other transducers, thermal biosensors do not need frequent 
recalibration and are insensitive to the optical and electrochemical properties of the 
sample. Common applications of this type of biosensor include the detection of pesticides 
and pathogenic bacteria [13]. 
2.2.2.4. Ion-Sensitive 
Ion-sensitive biosensors are field effect transistors (FETs) with an ion-sensitive surface. 
The electrical potential of the surface changes when the ions and the semiconductor 
interact with each other. The change in potential can then be measured. The ion-sensitive 
field effect transistors (ISFET) can be constructed by covering the sensor electrode with 
polymer layer that is selectively permeable to the analyte ions. Once the ions diffuse 
through the polymer layer, they bring about a change in the surface potential of the FET. 
This type of biosensor is sometimes referred to as enzyme field effect transistor (ENFET) 
and is mainly used to monitor pH [13]. 
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2.3. Conducting polymers 
Conducting polymers are organic materials that exhibit both metallic and semi-conductive 
nature and have a conjugation of σ electrons (single bonds) and π electrons (double bonds) 
along their backbone Polymers were viewed as insulating materials before the 1970’s [12, 
13]. A key discovery in the research of conducting polymers was made in 1977 by 
McDiarmid and his colleagues when they applied to polyaniline, which is a fundamentally 
insulating polymer, the same redox chemistry that was previously used by both D.E Weiss 
and Gill. From this it was discovered that the conductivity of polyaniline can be increased 
by exposing it to either oxidizing or reducing agents [13, 14].  
Conductive polymers are also called conjugated polymers because of the alternating single 
and double bonds in the polymer chain. Due to the special conjugation in their chains, 
they are able to de-localize the electrons throughout the whole system resulting in their 
sharing by many atoms [20]. The de-localized electrons may move around the whole 
system and become the charge carriers to make polymers conductive. Non-conductive 
polymers can be transformed into conducting forms through the removal of electrons from 
the backbone (resulting in cations) or alternatively, by addition of electrons to the 
backbone (resulting in anions). These anions and cations act as charge carriers, hopping 
from one site to another under the influence of an electrical field, thus increasing 
conductivity of the polymer [20]. The single and double bond conjugation possessed by 
conducting polymers gives them unusual properties such as electrical conductivity, low 
energy optical transitions, low ionization potential and high electron affinity. The higher 
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values of the electrical conductivity obtained in such organic polymers have led to the 
name ‘synthetic metals’ [12, 15].  
Nanocomposites and co-polymers have emerged as the better material for biosensor due to 
the fact that mechanical and chemical properties of conducting polymers can be improved 
by doping (electron addition) or de-doping (electron removal). Copolymers synthesized 
from the polypropylene imine dendrimers are currently under extensive research, 
academically, because of their properties which will be discussed in the following section. 
2.4. Dendrimers 
Dendrimers are bulky and complex molecules with very distinct chemical structures. They 
are almost perfectly monodispersed macromolecules (since they have a consistent size and 
form) that can exhibit a normal and highly branched three-dimensional structure [16]. 
Dendrimers have a spherical configuration with monomer units branching out from a 
central core. The structure is highly defined and organized. There are two general methods 
to synthesizing dendrimers, namely, the divergent and the convergent methods. There is a 
basic difference between these two approaches. In the divergent method, scheme 1, the 
dendrimer grows outwards from a multifunctional core molecule. To generate the first 
generation dendrimer molecule, the core molecule reacts with monomer molecules 
containing one reactive group and two inactive groups. The generated new edge of the 
molecule is then activated for further reactions with more monomers. This process is then 
repeated for numerous generations to build the dendrimer layer by layer [17]. 
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Scheme 1: The divergent method of synthesizing dendrimers. 
 The divergent method (Scheme 1) works well when producing large amounts of 
dendrimers, but it has problems that occur from both side and incomplete 
reactions of the terminal groups that bring about structural defects. To remedy 
both of these problems, large excess of reactants is essential, even though it brings 
difficulties when purifying the final product [12]. 
 
 
 
Scheme 2: The convergent method of synthesizing dendrimers [12]. 
 
In the convergent method (Scheme 2), the dendrimer is constructed stepwise, starting 
from the end groups and progressing inwards. When the growing branched polymeric 
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arms (also called dendrons) are large enough, they are attached to a multifunctional core 
molecule. The convergent growth approach has quite a few advantages. Using this 
approach, it is relatively easy to purify the desired product and the occurrence of defects 
in the final structure is minimized. It becomes possible to introduce subtle engineering 
into the dendritic structure by precise placement of functional groups at the periphery of 
the macromolecule [18, 19]. The convergent approach does not allow the formation of 
high generations because steric problems occur in the reactions of the dendrons and the 
core molecule [21]. 
2.4.1. Poly(propylene imine) (PPI) dendrimer 
N
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Figure 3: The structure of Poly(propylene imine) (PPI) dendrimer. 
Poly(propylene imine) dendrimers are synthesized by the divergent method and are grown 
by reiterative sequence consisting of a double Michael addition of acrylonitrile to the 
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primary amino groups followed by hydrogenation under pressure in the presence of Raney 
cobalt [22, 23. 24]. Poly(propylene imine) (PPI) dendrimers are highly branched 
macromolecules terminated with amino groups with a number of interesting 
characteristics [25, 26]. They can be used as hydrogen donors because of their high 
density of amino groups. Dendrimers, with their easily accessible multiple terminal or end 
functional group, are ideal for the construction of star-shaped polymers [25]. PPI 
dendrimers are of interest due to their unusual physical properties [27]. An important 
physical feature of PPI dendrimers is that their viscosity in solution and in melt is lower 
than that of linear polymers, and that the viscosity decreases with increase in molecular 
weight [28]. Theoretical studies of the PPI dendrimers have given rise to predictions of 
attractive properties of the molecule depending on the pH and salt concentration of the 
aqueous environment [25]. At low pH and low salt concentration, the interior tertiary 
amine groups are protonated leading to a repulsion of charges. This repulsion results in 
what is considered as an “extended conformation” of the PPI dendrimer. At high pH and 
high salt concentration, the tertiary amine groups are no longer protonated, leading to a 
collapse of the dendrimer onto itself [25]. Dendrimers have an important property, which 
is their tendency to form cationic structures under physiological conditions (pH 7.4). 
Under such conditions the primary amines on the surface of the dendrimer protonate 
readily [25]. 
The surface functionalities and core of the PPI dendrimers can be modified for a variety of 
applications, such as, molecular electronics, molecular recognition, catalysis, 
electroluminescent devices and sensors [29]. The σ bond- π bond conjugation of PPI 
dendrimers makes them ideal electron mediators, this property together with their high 
 
 
 
 
23 
compatibility with proteins, such as, enzymes, makes PPI dendrimers useful in the 
construction of biosensors [29, 30]. 
Different generations of dendrimers can be synthesized. The number of functional groups 
on the dendrimer surface increase exponentially as a function of generation, generation 1 
PPI dendrimer has four functional groups while generation 2 PPI dendrimer has eight 
[25]. Higher generations have interior void spaces that large enough to accommodate 
nanoscopic guests of various kinds. Generation 2 PPI dendrimer has more spaces to 
accommodate guests than generation 1 PPI dendrimer [25]. 
2.5. Cytochrome P450 2E1 
The Cytochrome P450 constitutes a super-family of heme-containing enzymes that 
catalyze the metabolism of a wide variety of endogenous and xenobiotic compounds [31, 
32-33]. This is accomplished through the activation of molecular oxygen by the heme 
group, a process that involves the delivery of two electrons to the P450 system followed 
by cleavage of the dioxygen bond, yielding water and an activated iron-oxygen species 
which reacts with substrates through a variety of mechanisms [34]. Cytochrome P450 
enzymes are responsible for the hydroxylation of a number of compounds including 
steroids, fatty acids, drugs, food additives, fungi, bacteria, alkanes and polyaromatic and 
polychlorinated hydrocarbons [32, 35]. 
In man most of the cytochrome P450 enzymes are found in the liver with a remarkable 
amount also found in the small intestine, around the microsomal part of the cytoplasm, in 
the endoplasmic reticulum as well as in the mitochondria [36]. Enzymes isolated from the 
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mitochondria are known as steroidogenic cytochrome enzymes since they are situated in 
single cell organisms and are phylogenetically older. Usually they consist of an iron-
sulphur protein, NADPH and NADH-dependant reductase and cytochrome P450 enzyme 
[32]. Xenobiotic enzymes are located in the smooth endoplasmic reticulum of cells, while 
some studies indicate that they have evolved during the period of plant-animal 
differentiation. They are constituted by NADPH: P450 reductase (FAD-and FMN- 
containing flavoprotein) and cytochrome P450 enzyme. The strength of these enzymes 
lies in their ability to metabolize foreign biological substances [37]. 
Cytochrome P450 2E1 (CYP2E1) is a member of the cytochrome P450 enzymes with 
diverse origins where they can be of bacterial, microsomal and mitochondrial origin [38]. 
CYP2E1 plays a role in the oxidative metabolism of a small range of substrates, solvents, 
and anaesthetics; these are a few of many important drug interactions mediated by 
CYP2E1 [32]. CYP2E1 has the smallest active site amongst all human cytochrome 
enzymes; this is consistent with the low molecular weights of many CYP2E1 substrates 
[32]. Among the available cytochrome P450 enzymes, CYP2E1 is notable for resulting in 
liver toxicity, due to the fact that CYP2E1 consists of over 50 % of the hepatic 
cytochrome P450 mRNA and 7 % of the hepatic cytochrome P450 protein [35]. CYP 
enzymes are associated with different types of reactions such as hydroxylation, 
epoxidation, dehalogenation, dehydrogenation and N-dealkylation which, together with 
the monooxygenation capabilities, has resulted in their application in biosensors and 
bioreactors [32]. In this study CYP2E1 employed for metabolism of pyrazinamide, an 
antituberculosis drug. Table1 indicates substrates, inducers and inhibitors of CYP2E1 
while the structure of CYP 2E1 is illustrated in Figure 3. 
 
 
 
 
25 
Table 1: Substrates, inducers and inhibitors of CYP2E1 
Substrates Inhibitors Inducers 
Anaesthetics: 
 Halothane 
 Enflurane 
 Isoflurane 
Strong: 
Diethyldithiocarbamate 
 
 
 Acetone 
 Ethanol 
 Isoniazid 
 Other: 
 Paracetamol 
 Dapsone 
 Theophylline 
 Ethanol 
 Ohlorzoxazone 
 Toluene 
 Isoniazid 
Unspecified: 
 Cimetidine 
 Disulfiram 
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Figure 4: Distal face of CYP2E1 rainbow colored from N terminus (blue) to C terminus 
(red) also showing the active site of CYP2E1 [32]. 
2.5.1. Kinetics of catalytic reaction of CYP enzymes: 
Cytochrome P450 enzymes (Figure 4) consist of iron-protoporphyrin IX active sites with 
axial thiolate of cysteine residues as fifth ligands. Cytochrome P450 enzymes at rest are in 
the ferric form (Fe
3+
), one electron reduction of the ferric form leads to a ferrous state 
(Fe
2+
). In most cases, these enzymes are octahedral and because of unpaired electrons in 
their 3d orbitals, they are practically all paramagnetic [33, 34-35]. Due to the presence of 
protoporphyrin IX, heme enzymes exhibit characteristic visible absorption spectra 
however, their spectra differ according to the identities of the lower axial ligands donated 
by the protein and the oxidation state of the iron, while the identities of the upper axial 
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ligands are donated by the substrates. The source of electrons in this type of system is 
from flavoproteins, ferrodoxin like proteins, NADPH, the mediator or an electrode [32].  
The mechanism for substrate hydroxylation by cytochrome enzymes, involves the 
following steps although there are still several details that still remain unsolved. 
  1st Step: When the substrate binds to the hexa-coordinated low-spin ferric enzyme, 
water is excluded from the active site resulting in a change in the 5-coordinate low 
spin state. This causes a decrease in polarity which is accompanied by the 
lowering of the redox potential by 110 mV to 130 mV which makes the first 
electron transfer step thermodynamically favourable, from its redox partner 
NADH or NADPH 
 2nd step: The transfer of the first electron from one of the redox partners reduces 
the ferric iron to the ferrous enzyme and this process is called reduction. 
 3rd step: This form of the enzyme can now bind molecular oxygen resulting in a 
ferrous-dioxygen (Fe
2+
- O2) complex. 
 4th step: The O2
2-
reacts with two protons from the surrounding solvent, thereby 
breaking the O-O bond to release a water molecule and a highly active iron-
oxoferryl intermediate.  
 5th step: One hydrogen atom is abstracted from the substrate by the intermediate to 
produce a one electron reduced ferryl species (Fe
IV
- OH) and a substrate radical. 
On the other hand, the ferryl species reacts with the C – H bond of the substrate in 
a concerted reaction without the radical intermediate formation. 
 6th step: The final step of the process is the formation of the enzyme product 
complex and the release of the product. The low-spin state of the enzyme is then 
regenerated 
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The reaction mechanism of the CYP enzymes is illustrated in the following scheme: 
 
 
Scheme 3: The mechanism pathway of CYP enzymes [32].
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EXPERIMENTAL METHODS 
Summary 
This chapter outlines the synthesis of second generation poly(propylene imine) dendrimer, 
nickel-poly(propylene imine) metallodendrimer and nickel-poly(propylene imine)-co-
polypyrrole star copolymer using appropriate reagents and routes as discussed below. 
The method of biosensor fabrication by immobilization of the CYP2E1 enzyme onto the 
star co-polymer platform is also stated. Finally, the star copolymer and its respective 
individual components were characterized using electrochemical, spectroscopic (FTIR 
and XRD) and microscopic (TEM and SEM) techniques. 
3.1. Reagents 
Reagent grade pyrrole (98%), pyrrole-2-aldehyde (98%), dichloromethane (98%), 
methanol (›99.9%), lithium per chlorate (99.9%), sodium phosphate dibasic dihydrate 
(HNa2O4P.2H2O ~ ≥99.5%), sodium phosphate monobasic dihydrate (H2NaO4P.2H2O ~ 
≥99%), nickel chloride hexahydrate (NiCl2.6H2O ~ 99.99%) and Generation 2 
poly(propylene imine) dendrimer were purchased from Sigma Aldrich. Ethanol (96.4%) 
was purchased from Kimix. Grade I 25% glutaraldehyde was purchased from sigma 
Aldrich. Bovin serum albumin (BSA) was purchased from Fluka. Alumina micro 
polishing pads were obtained from Buehler. Stock enzyme solutions of 2µM CYP2E1 
were prepared from CYP2E1 solution from sigma Aldrich (C5740). Stock solution of 
pyrazinamide was prepared from a 30 mg pyrazinamide powder from Sigma Aldrich. De-
ionized water, used throughout the experiments, was prepared with a Milli-Q water 
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purification system. Analytical grade argon gas, obtained from Afrox South Africa, was 
used for degassing the cell solutions. 
3.2. Instrumentation 
All electrochemical measurements were done using BASi epsilon from Bio Analytical 
Systems (BAS), Lafayette, USA. All cyclic voltammograms were recorded with a 
computer interfaced to BASi epsilon using a 10 mL electrochemical cell with a three-
electrode set up. The electrodes used in the study were (1) a platinum working electrode 
(A = 0.0201 cm
2
) from BAS, (2) platinum wire counter electrode from Sigma Aldrich and 
(3) a Ag/AgCl (kept in 3 M NaCl) reference electrode from BAS. Alumina micro 
polishing pads were obtained from Buehler, LL, USA and were used for polishing the 
platinum electrode before modification. HRTEM images were taken using Tecnai G2 
F20X-Twin MAT 200kV Field Emission Transmission Microscopy from FEI (Eindhoven, 
Netherlands).All FTIR spectra were recorded on Spectrum 100 FTIR spectrometer 
(PerkinElmer, USA) in a region of 400 to 4000 cm
-1
. All samples were dried using Buchi 
rotarvapor and buchi waterbath from Labotech. 
3.2.1. Electrochemical techniques 
Electrochemical techniques are used to interrogate the redox properties of the biosensors 
and their prospective platform components at the electrode surface which occur when a 
potential is applied. From the redox behaviour of different materials under different 
conditions, various parameters such as rate constant, diffusion coefficient, formal 
potential, film thickness, sensitivity, detection limits, surface concentration, solution 
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resistance, charge transfer resistance and process reversibility can be determined. 
However, the main limitation of voltammetric techniques is that the species under 
investigation must be either reducible or oxidizable in the range where both the electrode 
and the electrolyte are electrochemically inert. 
3.2.1.1. Cyclic voltammetry 
Amongst the electrochemical techniques, cyclic voltammetry (CV) has become an 
important and widely used versatile electroanalytical technique in many areas of 
chemistry [39, 40]. CV is used to investigate kinetics for understanding reaction 
intermediates, and for obtaining stability of reaction products and mechanisms of various 
reactions at electrode surfaces. This technique is also used in the measurement of kinetic 
rates and constants and determination of adsorption processes on surfaces, electron 
transfer and reaction mechanisms [25, 32]. This technique is based on altering the applied 
potential (E) at a working electrode in both the forward and reverse directions while 
applying different scan rates and monitoring the current (I). In many cases, the applied 
potential (E) is changed or the current is monitored over a period of time (t). Thus, all 
voltammetric techniques can be described as some function of E, I, and t. They are 
considered active techniques (as opposed to passive techniques such as potentiometry) due 
to the fact that the applied potential forces a change in the concentration of an 
electroactive species at the electrode surface by electrochemically reducing or oxidizing it 
[41, 42]. CV has a major drawback, which is the reduced sensitivity at very low levels of 
analyte concentration, brought about by currents caused by double-layer effects and other 
sources [41]. The most important parameters in a cyclic voltammogram are the peak 
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potentials (Epa, Epc) and peak currents (Ipa, Ipc) of the anodic and cathodic peaks, 
respectively. If the electron transfer process is fast compared with other processes (such as 
diffusion), the reaction is said to be electrochemically reversible, and the peak separation 
is given by: 
      Equation (1) 
where ΔEp = peak separation, Epc = cathodic peak potential, Epa = anodic peak potential, R 
= Gas Constant (8.314 J/M/K), T = absolute temperature (298.15 K), n = number of 
electrons (1), F = Faraday constant (96485 C/mol) 
therefore, for a reversible redox reaction at 25 °C with n electrons ΔEp should be 0.0592 
/nV [22]. 
The formal reduction potential (E
o
) for a reversible couple is given by: 
        Equation (2) 
Cyclic voltammograms, from this study, showed increased peak currents and potential 
shifts for the Ni-PPI-co-PPy than pure Ppy. PPI-2Py increased the effect of redox 
reactions on PPY when it was used to form a PPI-co-Py star copolymer; this was observed 
by increased peak currents after the electrochemical formation of the star copolymer [25]. 
This behaviour is attributed to the intrusion of the Ni-PPI metallodendrimer into the 
polymer backbone of PPy which alters its electronic properties by increasing the single 
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bond and double bond conjugation and thus increase the number of charge carriers, 
thereby leading to enhanced electrochemically activity of the copolymer. 
3.2.2. Spectroscopic techniques 
Spectroscopic techniques employ light to interact with matter and thus probe certain 
features of a sample to learn about its consistency or structure. Light is electromagnetic 
radiation, a phenomenon exhibiting different energies, and dependent on that energy, 
different molecular features can be probed. Spectroscopic techniques are the most highly 
sensitive and are non-destructive to samples, require small sample volumes and do not 
require complex sample preparations of biological samples. These features make them 
highly applicable in the characterization of small sample volumes.  
3.2.2.1. Fourier Transform Infra-Red spectroscopy (FTIR) 
“Fourier spectroscopy” is a general term that is used to describe the analysis of any 
varying signal into its constituent frequency components. Using the mathematical methods 
that are named after J.B.J. Fourier, that are extremely powerful in spectroscopy, Fourier 
transforms can be applied to a variety of spectroscopies including infrared spectroscopy 
known as Fourier transform infrared (FT-IR), nuclear magnetic resonance (NMR), and 
electron spin resonance (ESR) spectroscopy [25].  
FTIR is most useful for identifying the identifying types of chemical bonds (functional 
groups). It can be applied to the analysis of solids, liquids, and gasses. In infrared 
spectroscopy, IR radiation is passed through a sample, some of the infrared radiation is 
absorbed by the sample and some of it is passed through (transmitted). The wavelength of 
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light absorbed is characteristic of the chemical bond. The resulting spectrum represents 
the molecular absorption and transmission [3]. The spectrum works like a molecular 
fingerprint of the sample and a fingerprint is unique for each molecule, no two unique 
molecular structures produce the same infrared spectrum. This makes infrared 
spectroscopy useful for several types of analysis. FTIR was used to characterise PPI 
dendrimer, PPI-2Py dendrimer and PP-co-PPY star copolymer, the spectra of the moieties 
were recorded in the region 400 to 4000 cm
-1
, without mixing with KBr. The spectra 
obtained were used to identify the various functional groups in the star copolymer as well 
as those in the backbone chain of the dendrimers [25]. 
3.2.3. Microscopic techniques 
3.2.3.1 High resolution scanning electron microscopy (HRSEM) 
The HRSEM is one of the most flexible instruments available used for the examination or 
analysis of the morphology of nanomolecules and chemical composition characterization. 
HRSEM uses electrons rather than light to form an image of objects such as fractured 
metal components, foreign particles and residues, polymers and biological samples, 
among others [3]. It uses a focused beam of high energy electrons to generate a variety of 
signals at the surface of solid specimens [41]. In the HRSEM the electron beam traces 
over the object and interacts with the surface of the object, dislodging secondary electrons 
from the surface of the specimen in unique patterns. A secondary electron detector attracts 
those scattered electrons and, depending on the number of electrons that reach the 
detector, registers different levels of brightness on a monitor [42]. Additional sensors 
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detect backscattered electrons (electrons that reflect off the specimen's surface) and X-rays 
(emitted from beneath the specimen's surface). Dot by dot, row by row, an image of the 
original object is scanned onto a monitor for viewing [41]. The advantages associated with 
HRSEM include, among others, its ability to perform analysis of selected point locations 
on the sample and that it is non-destructive of the sample [3]. Areas ranging from 
approximately 1 cm to 5 microns can also be imaged in a scanning mode using 
conventional SEM techniques (magnification ranging from 20×to approximately 30,000×, 
and a spatial resolution of 50 to 100 nm). In the study it was used for the determination of 
the surface morphologies of G2 PPI-PPy and nickel-PPI-2Py metallodendrimer. SEM was 
used to study the morphology of PPI-co-PPY [81]. SEM was used for the characterization 
of poly(propylene imine)-based rhodium (I) metallodendrimers [26]. 
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Scheme 4: Parts of the SEM instrument [43]. 
3.2.3.2. High resolution transmission electron microscopy (HRTEM) 
In the TEM, only thin samples (which allow a fraction of the incident electron beam to go 
through them) can be studied. When an accelerated beam of electrons impinges upon a 
sample, a rich variety of interactions takes place [3]. The versatility of electron 
 
 
 
 
38 
microscopy and X-ray microanalysis is derived in large measure from this variety of 
interactions that the beam electrons undergo in the specimen. 
HRTEM is a microscopic technique operational when a beam of electrons is transmitted 
through an ultra-thin sample material, interacting with the sample as it passes through. 
The electrons behave as a light source with much lower wavelengths, making it possible 
to obtain resolutions a thousand times better than using light microscopes [42]. Depending 
on the density of the material present, some of the electrons are scattered and disappear 
from the beam, while at the bottom of the microscope, the unscattered electrons hit a 
fluorescent screen which gives rise to a "shadow image" of the sample in question with its 
different parts displayed in varied darkness according to their respective densities[41]. 
The interaction of the electrons with the sample creates an image which is magnified and 
focused onto an imaging device, such as a layer of photographic film, a fluorescent screen 
or to be detected by a sensor such as a CCD camera [25]. This instrument enables users to 
examine fine details, even as small as a single column of atoms, which is tens of 
thousands times smaller than the smallest resolvable object in a light microscope. This 
technique uses phase contrast resulting from an interference of several beams and 
determines whether the particle that makes the specimen are dispersed or agglomerated 
[32]. The technique is limited in high magnification imaging which requires high electron 
dose where by the specimen needs to be relatively insensitive. In this study HRTEM was 
used to confirm the size, shape and distribution of nickel-PPI-2Py metallodendrimer. 
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3.2.3.3. Energy Dispersive x-ray Spectroscopy (EDS) 
X-rays are electromagnetic radiations with wavelengths between 10
-8
 m and 10
-12
 m. They 
are part of the electromagnetic spectrum that includes wavelengths of electromagnetic 
radiation called visible light [44, 45-46]. 
The energy-dispersive X-ray spectroscopy (EDS, EDX, or XEDS), sometimes called 
energy dispersive X-ray analysis (EDXA) or energy dispersive X-ray microanalysis 
(EDXMA), is an analytical technique that can be coupled with HRSEM, HRTEM and 
Scanning Transmission Electron Microscopy (STEM) [44, 47]. When EDS is coupled 
with these imaging techniques, it can be used as an elemental analysis tool that is able to 
analyse samples as small as nanometers in diameter [47]. In EDS the impact of electron 
beam, from any of the above mentioned imaging techniques, on the sample produces X-
rays that are characteristic of the elements that form the sample. Its characterization 
capabilities are due in large part to the fundamental principle that each element has a 
unique atomic structure, allowing unique set of peaks on its X-ray emission spectrum . To 
stimulate the emission of characteristic X-rays from a specimen, a high-energy beam of 
charged particles such as electrons, protons or X-rays, is focused into the sample being 
studied [44, 47]. At rest, an atom within the sample contains ground state electrons in 
discrete energy levels or electron shells bound to the nucleus. The incident beam may 
excite an electron in an inner shell, ejecting it from the shell while creating an electron 
hole where the electron was [47]. An electron from an outer, higher energy shell then fills 
the hole, and the difference in energy between the higher energy shell and the lower 
energy shell may be released in the form of an X-ray. The number and energy of the X-
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rays emitted from a specimen can be measured by an energy-dispersive spectrometer [44]. 
As the energy of the X-rays is characteristic of the difference in energy between the two 
shells, and of the atomic structure of the element from which they were emitted, this 
allows the elemental composition of the specimen to be measured [47]. The EDS was used 
in this study to study the elemental properties of the Ni-PPI-2Py metallodendrimer. 
3.3. Methodology 
3.3.1. Synthesis of 2-pyrrole-functionalized second generation poly(propylene imine) 
dendrimer to G2 (PPI-2Py). 
The synthesis of PPI-2Py was carried out by, initially, a condensation reaction of PPI with 
2-pyrrole aldehyde. A reaction mixture containing PPI generation 2 (0.8886 g, 1.149 
mMol) and 2-pyrrole aldehyde (0.87144g, 9.149 mMol) in 50 mL dry methanol (50 mL) 
was magnetically stirred under a positive pressure of nitrogen gas for 2 days in a 100 mL 
3-necked round bottom flask. The methanol was removed by rotary evaporation, the 
residual oil was dissolved in 50 ml dichloromethane (DCM), and the organic phase was 
then washed with water (6 × 50 mL) to remove unreacted monomer. The DCM was 
removed by rotary evaporation and yielded the desired product, PPI-2Py, as orange oil. 
3.3.2. Synthesis of generation 2 Ni metallodendrimer (Ni-PPI-2Py) 
PPI-2Py (0.0880 g) was dissolved in ethanol (10 mL) in around bottom flask, under 
nitrogen. Nickel (II) chloride hexahydrate (0.064 g) was added to the solution and the 
reaction mixture was refluxed under nitrogen for 24 h. The solvent was evaporated via 
 
 
 
 
41 
rotary evaporation, yielding a green residue. The residue was dissolved in 
dichloromethane (DCM) (15 mL) and the solution was filtered by gravity filtration. The 
solvent was removed from the filtrate, producing a green solid which was washed with 
hexane (3 x 5 mL). The product was dried under vacuum, yielding a brown solid. The 
solid was dissolved in 1:2 methanol/ DCM mixture. 
                          
 
                              
Scheme 4: The chemical synthesis of Ni-PPI-Ppy. 
Methanol/48h 
s 
NiCl2.4H2O/N2 24h 
Polymerization 
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3.3.3. Pre-treatment of working electrode 
A platinum working electrode was polished with 1 μm, 0.5 μm and 0.03 μm alumina 
slurries in glassy polishing pads, minimum for 5 min on each pad. After polishing, the 
electrode was ultra-sonicated for about 15 min with distilled water and absolute ethanol, 
respectively, to remove any possible absorbed alumina crystals on the electrode surface, 
followed by rinsing carefully with distilled water. The above procedure resulted into a 
clean platinum working electrode.  
3.3.4. Preparation of Ni-PPI-PPy/Pt electrode 
3 μL Ni-PPI-2py was drop-coated onto platinum working electrode and dried at room 
temperature for 4 h. Onto the Ni-PPI-2Py/Pt electrode, polypyrrole was prepared by 
electropolymerization of the pyrrole monomer in 0.1 M LiClO4 supporting electrolyte. 
Polymerization was done at a potential of -800mV to +800 mV (vs Ag/AgCl) at a scan 
rate of 50mV/s for 30 cycles. 
3.3.5. Fabrication of CYP2E1 biosensor: Ni-PPI-PPy/CYP2E1/BSA/Glu/Pt 
CYP2E1 was immobilized on the Ni-PPI-PPy/Pt by drop-coating. 3 μL of a 1M CYP2E1 
enzyme solution, containing 2.0 mg BSA was carefully drop-coated onto the Ni-PPI-PPy 
modified Pt electrode. 2 μL of 2.5% glutaraldehyde solution was drop coated onto 
modified electrode. The enzyme-modified electrode was then covered with a tight fitting 
lid for the first 10 minutes to form a uniform layer, after which, the lid was removed and 
the enzyme layer was slightly dried for 40 min but still retaining wet camera after which 
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the prepared biosensor was immediately placed at 4 
o
C for at least 60 min. The CYP2E1-
based biosensor was denoted as Ni-PPI-PPy/CYP2E1/BSA/Glu/Pt. 
For comparison, a biosensor based on CYP2E1 only (fabricated onto the bare platinum 
electrode, denoted as CYP2E1/Pt) was fabricated as follows:  
3 μL of a 1 M CYP2E1 enzyme solution, containing 2.0 mg BSA was carefully drop-
coated onto the clean Pt electrode. 2 μL of 2.5% glutaraldehyde solution was drop-coated 
onto the resulting electrode. The enzyme modified electrode was covered in a tight fitting 
lid for first 10 minutes to allow the formation of a uniform layer. The lid was removed and 
the enzyme was allowed to dry for 4 h at 4 
o
C. The resulting electrode was rinsed with 
Phosphate buffer (PBS) to remove any physically adsorbed enzyme. The CYP2E1-based 
biosensor was denoted CYP2E1/Pt and was kept at 4 
o
C in 0.1 M PBS when not in use. 
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CHAPTER 4 
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RESULTS AND DISCUSSION 
Summary 
This chapter outlines and discusses the results obtained for the study based on developing 
the Ni-PPI-PPy/CYP2E1/BSA/Glu/Pt nanobiosensor for detection of pyrazinamide. This 
chapter deals specifically with the characterization of the structural, elemental and 
morphological properties of the biosensor platform using techniques such as FTIR, SEM, 
TEM, and EDS. The electrochemical studies of the nanobiosensor platform and the 
detection of PZA using CV are also included. 
4.1. Structural and morphological characterization of the Platform 
In the following section we will discuss the characterization use of the following 
techniques which, provides information regarding the elementary analysis, such as EDS, 
and morphological (Scanning electron microscopy and transmission electron microscopy) 
and structural (Furrier transformer infrared spectroscopy) 
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4.1.1. FTIR 
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Figure 5: FTIR of Ni-poly(propylene imine) dendrimer (black) and G2 functionalized 
poly(propylene imine) dendrimer (red). 
The FTIR spectra (Figure 5) of both Ni-PPI-2Py metallodendrimer and PPI-2Py show an 
out-of-plane bending of the C–H bond located at the α position in the pyrrole ring (729 
cm
-1
), and N=C band at 1634 cm
-1 
is assigned to the stretching vibration present in the 
dendrimer moiety [25]. The appearance of these two characteristic peaks confirms the 
functionalization of the amine groups of PPI by 2-Py. 
The FTIR spectra of both the G2 PPI-2py and the Ni PPI-2Py show the characteristic 
(NH), ν(C=C), ν(C-N) aliphatic bond bands at, 3413 cm-1,1642 cm-1,1306 cm-1 of the 
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pyrrole ring respectively. The FTIR spectrum of the metallodendrimer shows no 
disappearance in any of the peaks of the dendrimer due to the fact that none of the 
dendrimer bonds were broken in the formation of the metallodendrimer. The vibrations 
associated with large metals bound to light ligand atoms (e.g.,metal-nitrogen, M-N ) 
usually appear from 500 cm
-1
 to lower energies, the Ni-N bond normally appears within 
the broad range of 300 - 500 cm
-1
 [48, 49]. The dative bond Ni-N in the Ni-PPI-2Py 
metallodendrimer is a result of sharing of lone pairs of electron from the nitrogen atoms. 
Therefore in most cases this type of bond is referred to as an artificial bond [49, 50]. 
Dative bonds can sometimes be semi-polar and FTIR shows polar bonds [51]. This could 
be the reason why the Ni-N bond is not present in the metallodendrimer spectrum. 
 
 
 
 
 
 
 
Table 2: Types of bonds present in both the dendrimer and metallodendrimer and the 
frequencies that they appear on. 
Frequency, 
 cm
–1
 
Bond Type 
3400-3250 N-H 
1680-1640 -C=C 
1335-1250 C-N Stretch 
aromatic 
1600–1585 C-C Stretch 
1250-1220 C-N Stretch 
aliphatic 
2800-3000 CH Stretch  
1640-1690 C=N 
 
 
 
 
48 
4.1.2. Energy Dispersive X- Spectroscopy (EDS) 
s  
 
Figure 6: The Energy Dispersive X-ray spectrum of the (A) Ni-PPI-2py and (B) G2PPI-
2Py. 
             
A 
 
B 
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The EDS was used to study the elemental composition of the Ni-PPI-2Py 
metallodendrimer and G2PPI-2Py dendrimer (Figure 6A, B respectively). The EDS 
spectrum (Figure 5 A) revealed that the most abundant elements in the metallodendrimer 
are nickel (Ni) and Cl respectively. The EDS also showed the presence of minute amounts 
of copper (Cu) and oxygen (O). The presence of both the Cl and O is due to the metal 
precursor NiCl2·6H2O used to introduce the metal into the dendrimer framework during 
synthesis. The copper is a result of the copper grid used to hold the sample during the 
analysis. The EDS spectrum of G2PPI-2Py (Figure 5 B) indicates that the material showed 
the presence of nitrogen and carbon atoms, with chlorine being the impurity that was 
present in the compound. Carbon and the nitrogen were expected as the structure of 
G2PPI-2Py contains nitrogen and carbon atoms only.  
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4.1.3. High resolution scanning electron microscopy (HR-SEM) 
 
Figure 7(A): The HR-SEM image of the PPI-2Py. 
 
A 
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Figure 7(B): The HR-SEM image of the Ni-PPI-2Py. 
The PPI-2Py had a sticky paste-like texture. The HR-SEM images of PPi-2Py and Ni-PPI-
2Py (Figure 7 A and B respectively) show that the PPI-2Py and its morphology resembled 
that of densely clustered florets. The synthesis of the metallodendrimer required that the 
crystals be dissolved after collection. The morphology of the Ni-PPI-2Py shows that, after 
the incorporation of the metal into the dendrimer framework, crystals were formed. The 
B 
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formation of crystals suggests that the Ni-PPI-2Py metallodendrimer was successfully 
synthesized.  
4.1.4. High resolution transmission electron microscopy (HR-TEM) 
 
Figure 8(A): The HR-TEM micrograph of G2PPI-2Py. 
 
A 
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Figure 8(B): The HR-TEM micrograph of Ni-PPI-2Py. 
HRTEM determines the shape and size of nanoparticles. In this study it was used to 
determine the size and shape of nickel nanoparticles present in the Ni-PPI-2Py complex. 
Figures 8A and B represent the internal structures of the G2PPI-2Py and the Ni-PPI-2Py 
B 
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complexes. The structure of G2PPI-2Py shows the spherical shape of the dendrimer which 
is the typical shape of dendrimers. Figure 7B showed convincing results of shape, size and 
structure of the Ni-PPI-2Py metallodendrimer, observed with the 20 nm scale view. The 
micrograph showed that the crystals were poly-dispersed and their sizes were estimated to 
range between 10 and 16 nm, average being 12 nm. The shape of the metallodendrimer 
nanoparticles was mostly spherical and they are distributed as clusters.  
4.2. Electrochemical studies of the platform using cyclic voltammetry (CV) 
This section provides the discussion on the electrochemical studies of the platform. This 
includes the polymerization of the Ni-PPI-2py, the electrochemical studies of the 
polypyrrole, the electrochemical studies of the Ni-PPI-2Py and the detection of the 
pyrazinamide by the nanobiosensor. 
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4.2.1. Electropolymerization of polypyrrole 
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Figure 9: Electropolymerization of polypyrrole on the surface of Ni-PPI-2Py/Pt electrode, 
20 cycles at 50 mV/s from -800 to 800 mV (vs. Ag/AgCl). 
Figure 9 shows cyclic voltammograms for the electrochemical polymerization of pyrrole 
from +800 mV to -800 mV (vs Ag/AgCl) on Ni-PPI-2Py modified Pt electrode at a scan 
rate of 50 for 30 cycles in lithium perchlorate. At the initial oxidation step, the radical 
cation of the monomer is formed and reacts with other monomers present in solution to 
form oligomeric products and then the polymer. The current was observed to increase 
with increasing number of cycles, implying deposition of an electroactive material on the 
surface of the electrode. Growth of PPy is believed to take place from the α position of the 
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metallodendrimer, forming the Ni-PPI-co-PPY [25]. After the formation of black colored 
polymer film on the surface of the Ni-PPI-2Py, the electrode was taken out. 
 
4.2.2. Electrochemistry of polypyrrole 
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Figure 10: The Cyclic Voltammogram of polypyrrole in 0.1 M phosphate buffer. Taken 
from scan rates of 10-100 mV/s with 10 mV/s increments from -800 mV to +800 mV. 
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Figure 10 represents the cyclic voltammogram of polypyrrole in 0.1 M phosphate buffer 
pH 7.4 on the potential window of -800 mV to +800 mV. In the voltammogram there are 
two observable peaks, namely B and B’. The anodic peak B, at +700 mV is due to the 
oxidation of the pyrrole while the cathodic peak B’ at +471 mV is due to the deposited 
pyrrole onto the electrode surface. There is a shift of the anodic potential towards more 
positive potential with an increase in scan rate from +550 to +700 mV giving evidence of 
a more readily oxidised species. There is also an observable linear increase in the anodic 
peak current with an increase in scan rate, shown in figure 9, which indicates the 
occurrence of the electrochemistry of surface confined species. No shift in the cathodic 
peak current is observed; this indicates the presence a surface bound species. 
 
 
Figure 11: The Randles-Sevčik plot .of polypyrrole extrapolated from figure 10. 
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Figure 11shows the linear dependency of the current on the scan rate of the anodic peak B 
in figure 9. The Randles-Sevčik plot seems to indicate a thin surface bound electro-active 
polymer film. Furthermore the magnitude of the peak current was observed to increase 
with an increment of the scan rate suggesting that the peak current is diffusion controlled.  
Randle Sevčik Plot given, for analysis of diffusion controlled reactions: 
 
                  Equation (3) 
 
Where Ip = (Peak Current in μA), n = 1 (number of electrons), F = 96485 C/mol (Faradays 
Constant), A = 0.0201 cm
2
 (area of the electrode), C0 * = 
 
 mol/dm
2
 (Concentration of bulk 
substrate concentration), R = 8.314 J mol/ K (Gas Constant), T = 298.15 K (absolute 
Temperature) and ν = (Scan Rate in V/s) and D0 (diffusion co-efficient). 
 Do is the electron charge transport coefficient sometimes also known as the rate of 
electron charge propagation along the polymer chain. Figure 9 indicates an oxidation 
reaction that was occurring at Epa which was seen to be diffusion controlled with a 
correlation co-efficient of R
2
 = 0.977 and a diffusion co-efficient of Do = 3.4 X 10
-8
 cm
2
/s; 
indicating a faster electron transfer kinetics within the diffusion layer. Figure 9 shows that 
the cathodic peak potentials of the polypyrrole at B’, to overlap with an increase in scan 
rate suggesting a decrease in the rate of electron transfer. 
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Figure 12: Cyclic Voltammogram of Ni-PPI-PPY star copolymer in 0.1 M phosphate 
buffer. Cyclic voltammogram was taken from scan rates of 10-100 mV/s, with 10 mV/s
 
increments from -800 mV to +800 mV. 
Figure 12 shows the cyclic voltammogram of Ni-PPI-PPY, with 2 observable peaks 
donated C and C
l
. The oxidation state of the nickel in the complex was found to be +2. 
The number of electrons in the system were found to be n=1. ΔEp [Ep,a – Ep,c ] for the 
polymer film grown at different scan rates was calculated and found to be lower than 
65mV. This suggested that the polymer exhibited reversible and fast electrochemistry. The 
cathodic peak at +300 mV, denoted as C
l, 
is observed to be increasing with an increase in 
the scan rate. There is a slight cathodic shift in the peak potential; this is attributed to the 
extended conjugation in the polymer which results in the lowering of the oxidation 
 
 
 
 
60 
potential of the polymer. The anodic peak denoted by C, at 700mV is due to the change in 
the oxidation state of the nickel metal, this peak is represented by the mechanism Ni
+
--
Ni
2+
 +e. There is no shift in this peak with an increase in scan rate, this indicates a surface 
bound species, and thus the Ni-PPI-Ppy star copolymer is a surface bound species. 
 
Figure 13: Randles-Sevčik plot of Ni-PPI-PPY star copolymer in 0.1 M phosphate buffer 
extrapolated from figure 12.  
Figure 13 shows the e linear dependency of the current on the scan rate of the anodic peak 
C in figure 12. The Randles-Sevčik plot of Ni-PPI-PPY star copolymer indicates that the 
oxidation reaction occurring at Epa was diffusion controlled with correlation co-efficient 
of r
2
 = 0.999 and a diffusion co-efficient which was found to be Do = 5.7 X 10
-7
 cm
2
/s; 
indicating diffusion control and this was found to be higher than the diffusion coefficient 
calculated for polypyrrole (figure 10) which was found to be Do = 3.4 X 10
-8
 cm
2
/s. This 
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indicated that the Ni-PPI-PPY star copolymer increased the electron transfer, due to the 
increase in the conjugation of single (σ) and double (π) bonds, in the star copolymer due 
to the polymerization of polypyrrole and also the incorporation of the Ni metal into the 
framework of the star copolymer also plays a role in increasing the rate of electron 
movement in the star copolymer. 
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4.3. Biosensor characterization and detection of PZA 
4.3.1. Electrochemistry of Ni-PPI-PPy/CYP2E1/BSA/Glu/Pt 
 
Figure 14: (A). CV graph of (a) Ni-PPI-Ppy star copolymer/Pt, (b) CYP2E1/Pt and (c) 
Ni-PPI-Ppy star copolymer/CYP2E1/BSA/Glu/Pt nanobiosensor in 0.1 M phosphate 
buffer at 10 mV/s 
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Figure 14:. (B) a magnified CV of the star copolymer. 
Figure 14 shows the cyclic voltammograms of (a) Ni-PPI-Ppy star copolymer/Pt, (b) 
CYP2E1/Pt and (c) Ni-PPI-Ppy star copolymer/CYP2E1/BSA/Glu/Pt nanobiosensor in 
0.1 M phosphate buffer at 10 mV/s. The current response increases when the enzyme is 
immobilized on the surface of the electrode. The voltammogram of the Ni-PPI-Ppy star 
copolymer/Pt shows the lowest current response and is marginalized when overlaid with 
CYP2E1/Pt and Ni-PPI-Ppy star copolymer/CYP2E1/BSA/Glu/Pt. The highest current 
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response is observed when the CYP2E1 enzyme is immobilized on top of the star 
copolymer. 
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Figure 15: Cyclic voltammogram of Ni-PPI-PPY/Pt (red) and CYP2E1/Pt (black) 
(CYP2E1 enzyme on the surface of the bear Pt electrode) with 0.02 nM PZA in 0.1 
phosphate buffer at a scan rate of 10 mV/s from -800 to 400 mV (vs. Ag/AgCl). 
Figure 15 compares the response of the star copolymer and CYP2E1/Pt to the addition of 
PYZ concentrations. The voltammogram (Figure 15) is taken at a concentration 0.02nM 
PYZ, from the comparison it can be seen that the CYP2E1 gives a higher current response 
than the star copolymer, from that it can be seen that the enzyme is successfully 
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immobilized on the electrode and it metabolizes the PZA whereas the star copolymer 
gives minimal interaction as there is no enzyme to bind the PZA. 
4.3.2. Detection of PZA 
 
 
 
 
 
 
 
 
 
  
Figure 16: Cyclic Voltammogram of Ni-PPI-Ppy/CYP2E1/BSA/Glu/Pt with different 
concentrations of PZA in 0.1 phosphate buffer taken from -800 to 400 mV (vs. Ag/AgCl). 
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Figure 17: Cyclic Voltammogram of Ni-PPI-Ppy/CYP2E1/BSA/Glu/Pt with different 
concentrations of PZA in 0.1 phosphate buffer taken from -800 to -100 mV (vs. 
Ag/AgCl). 
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Figure 18: Calibration curve drawn from the linear region of the biosensor responses in 
figure 16. 
The electrochemical activity of the CYP2E1 nanobiosensor (Ni-PPI-
Ppy/CYP2E1/BSA/Glu/Pt) was evaluated using CV (Figure 16) in the presence of 
oxygen. From the CV it can be seen that the CYP2E1 nanobiosensor it exhibits one redox 
pair centred at -300 mV and -500 mV (vs. Ag/AgCl). This pair was attributed to the 
Fe
3+
/Fe
2+
 transitions of the CYP2E1 active site. This suggests that the electron transfer 
that occurred at -300 mV (vs Ag/AgCl). The cathodic peak at -500 mV (vs Ag/AgCl) is 
indicative of the reduction of PZA-CYP2E1-O2; this result is in agreement with the 
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mechanism for metabolic reaction of cytochrome P450 (haemolytic) enzymes (Scheme 3) 
[32, 3]. Thus, the -PPI-PPY star copolymer must have a great effect on the kinetics of 
electrode reaction providing a suitable environment for CYP2E1 to transfer electrons with 
the underlying electrode [3].  
The most important aspect of the study, detection of PZA, was interrogated using CV; 
figure 17 shows the reduction peak of the CYP2E1 nanobiosensor. The reduction peak 
was observed to increase with increase in the PZA concentration. This behaviour is 
attributed to the coupling of the fast electron transfer at the electrode surface with the 
reduction of PZA on or within the biosensor film [3]. The catalytic reduction mechanism 
of PZA by the biosensor is similar to the mechanism shown in scheme 3. The first step is 
the binding of PZA into the active site of CYP2E1 which is in the ferric resting state. An 
electron from the star copolymer modified electrode reduces the enzyme to the ferrous 
state which then binds to molecular oxygen. During this stage, PZA is hydroxylated to 5-
hydroxypyrazinamide. This is followed by the O-O bond cleavage by the introduction of 
the second electron resulting in a highly active iron-oxoferryl intermediate CYP2E1 
(Fe4+) with 5-hydroxypyrazinoic acid as the product which is released [3]. 
The peak currents of the CYP2E1 nanobiosensor seen in figure 16, have a linear 
relationship with PZA concentrations, as shown in figure 18, with a dynamic linear range  
of 0.01 nM-0.12 nM ( 1.231 – 7.386 ng/L PZA) The developed nanobiosensor shows a  
higher sensitivity (0.142 µA/nM) and lower limit of detection (LOD) of pyrazinamide  
0.00114 nM (0.14 ng/L) than that of chromatography at 500 mg of pyrazinamide is 40 
ng/L [52, 53- 
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54]. This result shows that the biosensor is able to detect concentrations lower than that 
[21]. From The HPLC analysis of human blood, the peak concentration (Cmax) of PZA 
determined 2 h after drug intake is 2.79 – 3.22 ng/L, which is very detectable with the 
nanobiosensor due to its high sensitivity [52, 53- 54]. 
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5.1 Conclusion 
Summary  
This chapter covers the various aspects (success and challenges) towards the achievement 
of the main aims of the study. Where necessary, the chapter also entails future 
investigations and related studies. 
This study has been conducted to develop a nanobiosensor for detection of an 
antituberculosis drug, pyrazinamide. The biosensor employed the heme enzyme, CYP2E1, 
immobilized onto a nickel-functionalized generation 2 poly(propylene imine) and 
polypyrrole star copolymer composite.  
A star copolymer is a branched polymer molecule in which a single branch point gives 
rise to multiple linear chains or arms. Forming star copolymers increases the conductivity 
of polymers. Conducting polymers typically contain as the fundamental structural unit a 
linear backbone of repeating conjugated monomers, exemplified by polyacetylene, 
polypyrrole, polyaniline, and polythiophene. In this study polypyrrole was used as the 
repeating conjugated monomer. Organic conducting and semiconducting polymers may be 
synthetically tailored to optimize desirable properties such as melting point, melt 
viscosity, solubility, electrical and thermal conductivity. In general, 
conductive/semiconducting polymers consist of a backbone of repeating monomer units 
with extended pi-electron delocalization. In this project, the electrical conductivity of the 
conducting polymers was utilized in fabricating the biosensor. The nickel poly(propylene 
imine)-co-polypyrrole star copolymer was used as the platform of the biosensor to 
increase the electron movement between the analyte and the electrode. The nickel 
poly(propylene imine)-co- polypyrrole star co polymer was found to increase the 
conductivity of the biosensor by making use of its conjugation of single and double bonds, 
hic act as charge carriers. 
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SEM, TEM, EDS and FTIR studies showed successful incorporation of the nickel in the 
dendrimeric polymer with a change in morphology, crystal structure and new elements. 
The polymerization of the metallodendrimer with pyrrole, thus forming the star copolymer 
(Ni-PPI-PPY) resulted in a copolymer platform with improved electroactivity due to the 
incorporation of the Ni metal into the framework of the PPI dendrimer and the increase in 
single bond- double bond conjugation the electropolymerization of pyrrole on the Ni-PPI-
2Py. This behaviour was investigated using CV where, after the formation of the star 
copolymer, the electroactivity was seen to improve due to the fact that electron transfer 
improved and peak currents increased. The CV results for the biosensor response towards 
different PZA concentrations confirmed that the Ni-PPI-Ppy/CYP2E1/BSA/Glu/Pt 
nanobiosensor successfully catalyzed the reduction of PZA into the main metabolite, 
pyrazinoic acid, well-known to destroy the TB bacteria. A calibration plot from the 
increasing PZA concentrations plotted against increasing currents was used to determine 
the sensitivity and limit of detection of the biosensor, which were found to be 0.142 
µA/nM and 0.00114 nM (0.14 ng/L) respectively. The linear range was found to be 0.01 
nM-0.12 nM (1.231 – 7.386 ng/L PZA).  
Ngece and colleagues fabricated a nanoparticulate of silver-modified poly(8-anilino-1 
naphthalene sulphonic acid) nanobiosensor systems for the determination of tuberculosis 
treatment drugs. Their biosensor was used to detect anti-Tuberculosis drugs, Isoniazid, 
Ethambutol, Rifampicin and Pyrazinamide. Using their biosensor to detect pyrazinamide, 
they found that the sensitivity of the -modified poly(8-anilino-1 naphthalene sulphonic 
acid) nanobiosensor system 1.38 µA/µM. The LOD and dynamic linear range were found 
to be 0.054µM and 0.054 µM-24 µM respectively. 
Sidwaba and colleagues developed a nanobiosensor for detecting pyrazinamide, using 
PANI incorporated with multiwalled carbon nanotubes as the platform. They found that 
the sensitivity and limit of detection of the biosensor were found to be 0.959 µA/µM and 
0.00916 µM (0.114 ng/L) respectively. 
 The cytochrome P4502E1/nickel-poly(propylene imine) dendrimeric nanobiosensor 
developed in this study is more sensitive than both biosensors, and can detect lower 
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concentrations than the two respective biosensors. The linear range of the cytochrome 
P4502E1/nickel-poly(propylene imine) dendrimeric nanobiosensor requires improvement. 
Overall, the developed novel nanobiosensor showed catalytic response towards detection 
of pyrazinamide. The fundamental point is the detection limit of the nanobiosensor which 
falls within the Cmax value of PZA determined by HPLC. Therefore, this compound is very 
detectable using this nanobiosensor. The biosensor is useful as it is more sensitive and is 
able to detect lower concentrations than other novel biosensors. 
Recommendations for Future Study:  
 The following aspects of the nanobiosensors for the determination of Pyrazinamide, a 
first line tuberculosis treatment drug presented in this work warrant further investigations.  
1. More work needs to be done to improve the electroactivity of PPI through the synthesis 
of higher generations.  
2. It is proposed that another enzyme with a bigger active site than CYP2E1 that can 
metabolize Pyrazinamide be used, so that the sensitivity and linear range can be increased. 
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